Serum LH levels are associated to serum insulin and Anti‐Müllerian hormone levels in women with both functional hypothalamic amenorrhoea and polycystic ovarian morphology

The aim of the study was to investigate whether serum Luteinizing Hormone (LH) levels in women with Functional Hypothalamic Amenorrhoea (FHA) and Polycystic Ovarian Morphology (PCOM) are still associated to Body Mass Index (BMI) and/or serum insulin and/or Anti‐Müllerian Hormone (AMH) levels using a larger population of FHA.

• Publication year

  2023

• Venue

  Clinical Endocrinology

• Publication date

  2023-03-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/cen.14912PMID 36912207
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional hypothalamic amenorrhea with or without polycystic ovarian morphology: a retrospective cohort study about insulin resistance.

  2022cited by this paper
• Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology

  2022cited by this paper
• Revisiting the serum level of anti-Müllerian hormone in patients with functional hypothalamic anovulation.

  2021cited by this paper
• Clinical and biochemical discriminants between functional hypothalamic amenorrhoea (FHA) and polycystic ovary syndrome (PCOS)

  2020cited by this paper
• New insights into anti-Müllerian hormone role in the hypothalamic–pituitary–gonadal axis and neuroendocrine development

  2020cited by this paper
• Recovery of menses after functional hypothalamic amenorrhoea: if, when and why.

  2020cited by this paper
• Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline.

  2017cited by this paper
• Comparative assessment of five serum antimüllerian hormone assays for the diagnosis of polycystic ovary syndrome.

  2016cited by this paper
• Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion

  2016cited by this paper
• Neuroendocrine causes of amenorrhea--an update.

  2015cited by this paper
• Functional hypothalamic amenorrhea and its influence on women’s health

  2014cited by this paper
• The role of AMH in anovulation associated with PCOS: a hypothesis.

  2014cited by this paper
• The physiology and clinical utility of anti-Mullerian hormone in women.

  2014cited by this paper
• Polycystic Ovary-Like Abnormalities (PCO-L) in women with functional hypothalamic amenorrhea.

  2012cited by this paper
• Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?

  2012cited by this paper
• Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries.

  2011cited by this paper
• Functional hypothalamic amenorrhoea: a partial and reversible gonadotrophin deficiency of nutritional origin

  1999cited by this paper
• Polycystic ovaries and associated clinical and biochemical features in young women

  1999cited by this paper
• The prevalence of polycystic ovaries in healthy women

  1999cited by this paper
• The Prevalence of Polycystic Ovaries on Ultrasound Scanning in a Population of Randomly Selected Women

  1994cited by this paper
• How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?

  1992cited by this paper
• Implications of ultrasonically diagnosed polycystic ovaries. I. Correlations with basal hormonal profiles.

  1992cited by this paper
• Polycystic ovaries--a common finding in normal women.

  1988cited by this paper
• Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells.

  1981cited by this paper

• AMH specifically targets neuronal AMHR2 to modulate the progression of polycystic ovary syndrome

  2026cites this paper
• GnRH ability to release FSH and LH in women with functional hypothalamic amenorrhea: a retrospective cohort study about women with and without polycystic ovarian morphology

  2025cites this paper
• Changes in anti-mullerian hormone levels after recovery from functional hypothalamic amenorrhea: a retrospective cohort study about women with and without polycystic ovarian morphology

  2025influential citation
• Distinguishing Polycystic Ovary Syndrome Phenotype D from Functional Hypothalamic Amenorrhea with Polycystic Ovarian Morphology: Clinical and Hormonal Insights from a Pilot Retrospective Study

  2025cites this paper
• Pulsatile GnRH therapy: comparison of efficacy between Functional Hypothalamic Amenorrhea and Congenital Hypogonadotropic Hypogonadism.

  2024cites this paper
• Functional hypothalamic amenorrhoea and polycystic ovarian morphology: a narrative review about an intriguing association

  2024cites this paper
• Prolactin levels in functional hypothalamic amenorrhea: a retrospective case–control study

  2023cites this paper